Table 3.
Prevalence of hepatitis B virus infection and genotype distribution in some eastern European countries
| Countries | HBsAg prevalence[133-138,142-145,147,148] | HBV genotype distribution[150-156,160,161] |
| Albania | > 9% | A: Eastern Europe (Poland, |
| Czech Republic, Bulgaria, | ||
| Hungary1) | ||
| A2 Bulgaria | ||
| D: Southeastern Europe (Russia, the Baltic region, Belarus, Romania, Hungary, Serbia, Croatia, Lithuania, Romania, Bulgaria)1 | ||
| D1 Bulgaria | ||
| D2 Albania, Russia, Estonia, the Siberian and eastern part of the former USSR | ||
| Bulgaria | 3.80% | D3 Serbia |
| Croatia | 1.7%-15.8% | [D: prevalent genotype (70%-80%)] |
| Poland | 3.91/1000001 | |
| Romania | 5.59% | 1A,D: equal distribution |
| Russia | 7.6/100000 | |
| Serbia | 4.4%-13% |
1
Incidence/year. HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus.